Evidence map›Paper›PMID 33781384›Full record

ArticleeLife2021

A common 1.6 mb Y-chromosomal inversion predisposes to subsequent deletions and severe spermatogenic failure in humans.

Pille Hallast, Laura Kibena, Margus Punab, Elena Arciero, Siiri Rootsi, Marina Grigorova, Rodrigo Flores, Mark A Jobling, Olev Poolamets, Kristjan Pomm and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Repetitive DNA Sequences in the Human Y Chromosome and Male Infertility.Frontiers in cell and developmental biology · 2022
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Pille HallastInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.ORCID 0000-0002-0588-3987
Laura KibenaInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Margus PunabAndrology Unit, Tartu University Hospital, Tartu, Estonia.
Elena ArcieroWellcome Genome Campus, Wellcome Sanger Institute, Hinxton, Cambridge, United Kingdom.
Siiri RootsiInstitute of Genomics, Estonian Biocentre, University of Tartu, Tartu, Estonia.
Marina GrigorovaInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Rodrigo FloresInstitute of Genomics, Estonian Biocentre, University of Tartu, Tartu, Estonia.
Mark A JoblingDepartment of Genetics & Genome Biology, University of Leicester, Leicester, United Kingdom.
Olev PoolametsAndrology Unit, Tartu University Hospital, Tartu, Estonia.
Kristjan PommAndrology Unit, Tartu University Hospital, Tartu, Estonia.
Paul KorrovitsAndrology Unit, Tartu University Hospital, Tartu, Estonia.
Kristiina RullInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Yali XueWellcome Genome Campus, Wellcome Sanger Institute, Hinxton, Cambridge, United Kingdom.
Chris Tyler-Smith *Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, Cambridge, United Kingdom.
Maris Laan *Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.ORCID 0000-0002-8519-243X
Tartu University Hospital · EEWellcome Sanger Institute · GBUniversity of Tartu · EEEstonian Biocentre · EEUniversity of Leicester · GB

Funding

ROLE OF MELATONIN IN SECONDARY INSOMNIA IN THE ELDERLYK23AG001021 · NIA · UNIVERSITY OF PENNSYLVANIA · PI GOONERATNE, NALAKA S · 2000 to 2004
$685k
Estonian Research Council IUT24-1Estonian Research Council IUT34-12Estonian Research Council MOBTT53Estonian Research Council PRG1021Estonian Research Council PUT1036Estonian Research Council PUT181European Regional Development Fund 3.2.0701.12-004Wellcome Trust 098051
6 · The paper itself

Abstract

Male infertility is a prevalent condition, affecting 5-10% of men. So far, few genetic factors have been described as contributors to spermatogenic failure. Here, we report the first re-sequencing study of the Y-chromosomal

Indexed as

Gene DeletionAdolescentAdultAzoospermiaChromosome InversionEstoniaHumansMaleMiddle AgedSpermatogenesisYoung Adultb2/b3 deletionscomplex structural rearrangementsdaz, bpy2, cdy1 dosageevolutionary biologygeneticsgenomicsgr/grhumanidiopathic male infertilityvariantsy-chromosomal azfc regiony haplogroup r1a1-m458

Identifiers

PMID33781384
PMCPMC8009663
OpenAlexW3147782107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.